The drugmaker’s U.S. expansion comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% ...

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...

On the downside, GSK's COVID-19 therapy Xevudy (sotrovimab) saw a slump in demand, with sales falling to £500 million from £1.3 billion in the first quarter of 2022, and GSK is expecting the ...

Sherman Yu, GSK Vice President and GSK China General Manager ... In the vaccines area, highlights include Shingrix, which is a recombinant shingles vaccine that combines antigens and adjuvant systems ...

Dubai, United Arab Emirates – Dubai Health Authority (DHA) and GSK, a global science-led UK healthcare company, have signed a General Collaboration Agreement (GCA) tackling adult immunization ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

As of October 31, 2024, GSK plc (ADR) had a $73.6 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc (ADR)’s ...

© 2024 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.